identikit
Footballguy
Yes.Article doesn’t mention the company though. Might not be a big deal but not sure I would expect it to pop Monday. Hope so though!
Disappointing.
Yes.Article doesn’t mention the company though. Might not be a big deal but not sure I would expect it to pop Monday. Hope so though!
The piece on CBS had it on upper left. At least stock symbolArticle doesn’t mention the company though. Might not be a big deal but not sure I would expect it to pop Monday. Hope so though!
The CEO is terrible in front of a camera. They need a real communicator then get rid of these paid puff pieces. My 2 cents.It's good to hear from an actual patient instead of paid interviews.
Wish the national media would pick it up.
I think I prefer it that way.. focus on the drug and anecdotal evidence.Article doesn’t mention the company though. Might not be a big deal but not sure I would expect it to pop Monday. Hope so though!
The market definitely reacts negatively to uncertainty. It's been better in the past week, probably because of some of the news about the curves in cities beginning to peak and the money put into stabilize the economy. It will be interesting to see if the federal governments' recommendations to open the government will cause any doubt about the recovery if they get too far ahead. I don't doubt that many governors are not going to want to move as fast as Trump, but I do believe this will quickly become a bi-partisan issue by June as job losses continue to mount. Obviously, the medical data matters though.If the market is so forward thinking then why would it EVER go down? The only thing that is 100% a sure thing is that the market always recovers and then goes up. Always. Every time. It has never NOT done that. Ever.
I don't think we're be operating a full economy until a vaccine is back. Entertainment, travel, restaurants, large group gatherings may be 'open', but aren't going to be widely used until then. I am actually more optimistic about the fall, when a 2nd wave of the virus is expected/could come back than I am about June/July as the economy re-opens. I say this because until we have a theraputic, we can only bounce back so much. If we have a medical answer to make a hospital visit an extreme scenario by the fall, then things could get back to somewhat normal, even though the vaccine is fully needed.Who doesn't realize that we aren't getting back to normal anytime soon?
Even the stocks that have explicitly said "we're not getting back to normal any time soon" have gone up.
Why AT&T?I own just a handful of stocks (25) and bought most of them around $38 or so. They don't seem to have much upside, but are a good dividend stock. How much you looking at?I'm looking at adding Appian and AT&T this week.
I did buy some United, but it's a stock that I realize nobody is going to be flying for a year. I'm thinking longer-term with them, at least a year out before people are comfortable with flying again.They can save the industry....without saving the common stock holders. This is why I am not touching airlines....and DAL is the only one I would even consider. And you have to be willing to lose every penny of what you put into any of those stocks.
Todem likes AT&T so he can probably give you the bull case. Personally, I prefer VZ to T. You're giving up some yield in the dividend but I think it's worth it. At this point, VZ is more of a pure play telecom company while AT&T is all over the place. Still predominantly a telco player but have a dying satellite TV business and I'm still not sure I understand the synergies between them and Time Warner. They're an over-levered compared to VZ which will impact their investment capacity going forward. Haven't modeled out T lately but their dividend payout ratio is over 100% which is unsustainable compared to VZ at 50%. At this point, I like the pureplay telecom company and VZ will be able to invest more for 5G than T will.The Lost One said:So just a dead end then?
I like VZ because it has more growth potential than T....but T’s dividend is outstanding and I think they will shed underperforming assets over time. T is cheap. When it goes into the mid to low 20’s I have been a big buyer. The compounded yield over 10-15 years....hard to argue with that. And T does have low volatility (lower beta) compared with the S&P 500 in general (nothing performed here well in this recent downtown).Great info, thx for sharing. Have Verizon on my watch list as well. A little more expensive to get into, less in dividends but I prefer VZ myself. And yes, I do think Todem recommended AT&T as well. He also recommended VZ too though.
Well to be fair, the Fed only used ~43% of the $454 billion Congress gave them. Gotta love leverage. So they have another up to $3T they can throw on the market assuming they lever the facilities up to 10x as they have been doing.25% in / 75% cash after Thursday/Friday
Let's see if the Fed throws another Trillion or two this week
![]()
If he sold 330M off and that is it it’s real bad timing.Buffet sure boned it on the airlines. AAL is going to open at about 50% above where it was a week ago.
Every week is alternating between fed announcement and Congress working on stimulus number infinity+125% in / 75% cash after Thursday/Friday
Let's see if the Fed throws another Trillion or two this week
![]()
Todem, how do you feel on this one? Still holding off for now?So.....how about this little diddy for when we feel the tide is finally turning?
EXIV
Velocity shares 1X daily INV on the VIX
52 week high was 51.40
It closed at 5.75 today.
Inverse ETF on the VIX
I am going to wait a little bit.......then make a small wager on this. Because the VIX is at all time highs.....and it could be here for a little while longer......but soon that levee is gonna break.
I typically stay far away from inverse ETN’s and ETF’s. 99% of the time they are losers. Pure timing and you have to be in and out to have any chance at success.Todem, how do you feel on this one? Still holding off for now?
On a related note, I had picked up a few shares of EXIV. I then received a “bond/cd redemption alert - full call” on it a week or so later. So did that basically force the sale at that price? Is this ticker now “closed”?
Seems like a solid strategy. I’d be curious to better understand what exactly that full call did, though?I typically stay far away from inverse ETN’s and ETF’s. 99% of the time they are losers. Pure timing and you have to be in and out to have any chance at success.
I am doing what I do best. Picking stocks....staying long. And making some quick trades inside of this bear market on oversold high stress stocks (BLMN, MGM for example).
I picked up some DIS as it dipped below 100.Any buyers today, or is it just the beginning?
Who knows. This is how people get separated from their $. Imagine trying to buy TZA or TNA right now. Have any idea which one to choose?Any buyers today, or is it just the beginning?
Seems like it has ceased to exist (without even looking it up) and they called it in and gave back whatever the value was at he moment.Seems like a solid strategy. I’d be curious to better understand what exactly that full call did, though?
-10% today. Maybe I’ll buy more at 6 lolI sold bloomin at 9.50. Kept saying I would hold but you gotta be an ###hole not to take 50% return. I’ll buy more at 7
Contemplating - Disney at $100, more JETS ($14?) or sit on some cash? DFS might be a good bye today too.
Very likely longer than YOU are currently pricing in. So many people incorrectly assume that their opinion is the opinion of the market and it's rarely true.I know we aren't supposed to "fight the Fed", but how much can they really do if people aren't leaving their homes?
The women's Rogers Cup tennis tournament was just cancelled in Canada, was supposed to be in mid-August. Quebec announced no sporting events can be held through August 31st (though it left the door slightly open for pro teams).
This is going to drag on for a lot longer than is currently being priced in IMO.
Same here.Grabbed a slice of DIS at 101.5
Holding onto this one for a while.Experimental coronavirus treatment leronlimab shows 'very promising' response in some COVID-19 patients
https://www.foxnews.com/science/experimental-coronavirus-treatment-leronlimab-very-promising-response-in-some-covid-19-patients
The experimental coronavirus treatment leronlimab has shown a “very promising” response in COVID-19 patients with mild-to-moderate symptoms, according to developer CytoDyn.
Leronlimab is a viral-entry inhibitor that targets HIV and breast cancer. The drug has also been attracting attention as a potential coronavirus treatment. In a statement released Monday CytoDyn gave an update on over 30 patients COVID-19 patients recently treated with leronlimab in more than 4 hospitals and clinics across the U.S. Patients have received leronlimab as part of Emergency Investigational New Drug (EINDs) treatments authorized by the FDA and two CytoDyn clinical trials.
“More than 25 patients have been administered leronlimab under EINDs authorized by the U.S. Food and Drug Administration (FDA),” the biotech explained. “Rate of response in mild-to-moderate patients under EIND has been very promising with the first five patients treated being removed from oxygen.”
Leronlimab is one of a number of drugs in the spotlight as the world scrambles to contain the coronavirus pandemic. Experts, however, have warned that people should not take drugs unless prescribed by a doctor.
CytoDyn CEO Nader Pourhassan said that the company is working to ramp up its research into leronlimab as a potential coronavirus treatment. “We continue to coordinate around the clock with healthcare professionals across the country to deliver leronlimab to patients and we are in regular contact with the FDA to ensure they receive current patient data,” he said, in the statement. “We are planning to rapidly enroll 75 patients and report the results to the FDA as quickly as possible.”
The Vancouver, Washington-based company said that, as of last week, 12 patients have been treated in a Phase 2 trial for mild-to-moderate COVID-19 indications. However, results are not yet available. The first site cleared to enroll patients in a Phase 2b/3 trial starts Monday, according to the biotech.
More than 25 hospitals have requested to participate in the company’s trials.
The FDA had already granted CytoDyn a “fast-track” designation for two potential uses of leronlimab – as a combination therapy with other medications for HIV patients and for patients with metastatic triple-negative breast cancer. Leronlimab blocks CCR5 (C-C motif chemokine receptor 5), a cellular receptor important in HIV infection, tumor metastases, and other diseases, according to CytoDyn. “Leronlimab has completed nine clinical trials in over 800 people, including meeting its primary endpoints in a pivotal Phase 3 trial (leronlimab in combination with standard antiretroviral therapies in HIV-infected treatment-experienced patients),” explained CytoDyn, in the statement.
Separately, the experimental COVID-19 treatment remdesivir is showing early promise in the battle against the coronavirus outbreak, according to a small research study.
The study, which was recently published in the New England Journal of Medicine, was supported by remdesivir developer Gilead Sciences.
As of Monday morning, at least 1.86 million coronavirus cases have been diagnosed worldwide, at least 557,663 of which are in the U.S. The disease has accounted for at least 115,286 deaths around the world, including more than 22,000 people in the U.S.
Seems like you're projecting here- I've said it before and I'll say it again that I've been doing this long enough and am humble enough to know that no one knows what is going to happen, especially when dealing with things we have never dealt with before.Very likely longer than YOU are currently pricing in. So many people incorrectly assume that their opinion is the opinion of the market and it's rarely true.
Still long in GOLD, FNV and NEM. Check the 1 year charts on those suckers (or any time range).I mentioned them in this thread a couple of weeks ago. Them and FNV and NEM.
Has been a really good group of gold investments for me lately.
Agree.....and also the essence of speculation....because this is what investing comes down to, is where everyone forms their opinions. I have no idea what is going to happen. I don’t even think the doctors know.Seems like you're projecting here- I've said it before and I'll say it again that I've been doing this long enough and am humble enough to know that no one knows what is going to happen, especially when dealing with things we have never dealt with before.